Sector revisions Abbisko Cayman Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:03 11/05/2026 BST			5-day change	1st Jan Change
11.61 ^HKD	-0.77%		-10.14%	-10.76%

04-29	Abbisko Completes HK$523 Million Share Offering	MT
04-23	Abbisko Therapeutics Showcases Six Research Advances Highlighting Pan-KRAS, 4th Generation EGFR, And Synthetic Lethality Approaches	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
ABBISKO CAYMAN LIMITED				7
ARGENX SE				15
WUXI APPTEC CO., LTD.				17
BIONTECH SE				18
INSMED INCORPORATED				20
WUXI BIOLOGICS (CAYMAN) INC.				21
GENMAB A/S				14
AKESO, INC.				21
SUMMIT THERAPEUTICS INC.				14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
EXELIXIS, INC.				17
MADRIGAL PHARMACEUTICALS, INC.				12
ARROWHEAD PHARMACEUTICALS, INC.				12
CYTOKINETICS, INCORPORATED				19
REMEGEN CO., LTD.				15
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
IMMUNITYBIO, INC.				4
PHARMAESSENTIA CORPORATION				6
NUVALENT, INC.				18
Average				14
Weighted average by Cap.				16